Dow Down 0.22% Nasdaq Up 0.14%

Alkermes plc (ALKS)

-NasdaqGS
43.24 Up 0.10(0.23%) Aug 22, 4:00PM EDT
Prev Close:43.14
Open:43.08
Bid:39.04 x 100
Ask:51.48 x 100
1y Target Est:50.92
Beta:1.57
Next Earnings Date:N/A
Day's Range:42.54 - 43.34
52wk Range:29.36 - 54.25
Volume:507,782
Avg Vol (3m):738,586
Market Cap:6.31B
P/E (ttm):N/A
EPS (ttm):-0.03
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALKS

Comparison

Symbol% ChgMkt Cap
ALKSUp 0.23%6.31B
ABTDown 0.50%63.32B
LLYUp 0.47%66.79B
GSKDown 0.04%114.53B

Key Statistics

Forward P/E (1 yr):72.07
P/S (ttm):11.26
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.27
Quarterly EPS Est (Sep-14) :0.02
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):12.10

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alkermes Public Limited Company, an integrated biopharmaceutical company, develops medicines that enhance patient outcomes. The company offers RISPERDAL CONSTA for schizophrenia and bipolar I disorder; INVEGA SUSTENNA to treat schizophrenia; AMPYR... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback